Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Saad Insider Profile
4 Followers
Mark Saad, CFO at Plus Therapeutics, holds 10.30K shares in Axsome Therapeutics (Ticker: AXSM), holds 13.75K shares in Catheter Precision (Ticker: VTAK), holds 276.86K shares in Plus Therapeutics (Ticker: PSTV).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+141.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Saad holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 24, 2019 - May 24, 2020
Return:+227.10%
The most profitable trade made by Mark Saad
Mark Saad's Trading History
Plus Therapeutics
Feb 04, 2013
CFO
Uninformative Sell
―
$332.23K
Axsome Therapeutics
Sep 11, 2024
Director
Uninformative Buy
40.43K
$1.42M
Catheter Precision
Jan 07, 2021
Director
Uninformative Buy
―
$4.77K
List of latest transactions for each holding click on a transaction to see Mark Saad's performance on stock
You May Also Like
Mark Saad insider profile FAQ
What is the percentage of profitable transactions made by Mark Saad?
The percentage of profitable transactions made by Mark Saad is 100%.
What is the average return per transaction made by Mark Saad?
The average return per transaction made by Mark Saad is 141.90%.
What stocks does Mark Saad hold?
Mark Saad holds: PSTV, AXSM, VTAK stocks.
What was Mark Saad’s latest transaction?
Mark Saad latest transaction was an Uninformative Buy of $40.43K.
What was Mark Saad's most profitable transaction?
Mark Saad’s most profitable transaction was an Informative Buy of AXSM stock on May 24, 2019. The return on the trade was 227.10%.
What is Mark Saad's role in Plus Therapeutics?
Mark Saad's role in Plus Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.